Search
for
Sort by
Research 421–450 of 923
- Efficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated analysis of the ALLEGRO phase IIb/III and long-term phase III clinical studies in alopecia areata
- Camouflage technique for alopecia areata: What is a patient to do?
- Prostanoids and Hair Follicles: Implications for Therapy of Hair Disorders
- Successful use of bimatoprost in the treatment of alopecia of the eyelashes
- Alopecia areata: Part 2: treatment.
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Filamin A Mediates Wound Closure by Promoting Elastic Deformation and Maintenance of Tension in the Collagen Matrix
- Switching JAK inhibitors: evaluating baricitinib’s effectiveness in alopecia areata after tofacitinib failure
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Pili Annulati: A case series and proposal for classification
- Ritlecitinib Efficacy in Adolescents With Alopecia Areata: A Real‐World Experience
- Defining a Therapeutic Window of Opportunity in Alopecia Areata: Predictors of Early Response to Baricitinib
- Efficacy of Janus Kinase Inhibitors in Alopecia in Jordanian Patients: A Retrospective Cohort Study
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Frontal Fibrosing Alopecia: A Comprehensive Review with Recent Updates
- Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study
- Demographics and Disease Characteristics of Patients with Alopecia Areata with Comorbid Atopic Dermatitis, Vitiligo or Anxiety/Depression: TARGET-DERM AA
- 49690 Long-term efficacy of baricitinib in alopecia areata: 3-year results from BRAVE-AA1 and BRAVE-AA2
- Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients
- Are all adverse effects undesirable? a case of chemotherapy induced adverse effect- an exception!?
- OVS Announces
- Frontal fibrosing alopecia and lichen planus pigmentosus
- A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia
- Successful Treatment of Pediatric Alopecia Areata of the Scalp Using Topical Bimatoprost
- Successful rapid subcutaneous desensitization to anakinra in a case of delayed‐type hypersensitivity reaction
- Acquired progressive kinking of hair affecting the scalp and eyelashes in an adult woman
- Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial
- Hypertrichosis and Increased Pigmentation of Eyelashes and Adjacent Hair in the Region of the Ipsilateral Eyelids of Patients Treated with Unilateral Topical Latanoprost
- Does prostaglandin D<sub>2</sub> hold the cure to male pattern baldness?
- The prostamide‐related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias